Bristol Royal Infirmary, Replaces Existing Imaging Systems with Advanced Agfa HealthCare Digital Radiography

Agfa HealthCareAgfa HealthCare announced that the Bristol Royal Infirmary has replaced its existing computed radiography (CR) systems with Agfa HealthCare CR, including five CR 30-X digitizers and four advanced, high-throughput CR solutions. All of the new systems being implemented come with Agfa HealthCare's gold-standard MUSICA image processing and workstation, which supports a highly efficient and optimized radiology workflow. The agreement also includes a DRYSTAR 5300 next-to-application direct digital printer.

The Bristol Royal Infirmary (BRI) is a teaching hospital providing acute medicine and surgery, critical care, trauma, orthopedic and accident and emergency services to the population of Bristol, UK. It is one of eight hospitals within the University Hospitals Bristol NHS Foundation Trust, and one of the oldest Infirmaries in the UK. Since 2011, it has been undergoing a major redevelopment, including a new accommodation block and refurbishment of the existing wards.

Potential dose reduction, smoother workflow, excellent image quality
The four new advanced Agfa HealthCare high-throughput CR systems unite excellent image quality with a drop-and-go buffer that can handle a mix of five cassettes of different sizes, for a smoother, more productive workflow. They support both standard phosphor plates and cesium-bromide (CsBr) needle detectors. Studies have shown dose reductions of up to 60% can be achieved with cesium-based detectors[1].

The CR 30-X is a highly versatile digitizer that offers no-compromises image quality for a broad range of applications. It reads imaging plates at the high resolution of 10 pixels/mm for all image plate sizes.

Exam-independent, automatic optimization of image quality and workflow
Both the advanced high-throughput CR systems and the CR 30-X come with MUSICA image processing software and workstation. Fully automatic and exam-independent, MUSICA provides consistently high image quality, while the workstation platform improves workflow and reduces waiting and examination times, to optimize patient care.

The Bristol Royal Infirmary is also implementing a DRYSTAR 5300 direct digital printer, offering convenient next-to-application installation in a solution requiring low investment and running costs.

Advanced tools support patient care objectives
"Our hospital's overall mission is to provide patient care of the highest quality; implementing advanced tools and systems such as Agfa HealthCare's CR solutions clearly demonstrate how we are following up on this commitment," says Simon Brown, Superintendent Radiographer of Bristol Royal Infirmary. "We chose these solutions as they will support us with faster processing, combined with higher resolution images and the potential to reduce radiation dose, to enhance our overall patient care."

"We are very proud that Bristol Royal Infirmary has chosen our advanced CR solutions to replace their existing CR imaging systems and support the hospital's ongoing mission with solutions and services that meet its needs." comments John Flavell, Imaging Business Manager of Agfa HealthCare UK.

1. Testing with board certified radiologists has determined that cesium bromide (CR) and cesium iodide (DR) detectors when used with MUSICA processing can provide dose reductions of between 50 to 60% when compared to traditional barium fluoro bromide CR systems. Contact Agfa HealthCare for more details.

Related news articles:

About Agfa
The Agfa-Gevaert Group is one of the world’s leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,865 million euro in 2013.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's. Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2013 were 1,160 million euro.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...